Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Odiparcil For The Prevention Of Venous Thromboembolism

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
GlaxoSmithKline
ClinicalTrials.gov Identifier:
NCT00244725
First received: October 25, 2005
Last updated: April 14, 2015
Last verified: April 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: September 2006
  Primary Completion Date: September 2006 (Final data collection date for primary outcome measure)